Another small molecular inhibitor, IT-139, has been shown to suppress GRP78 induction in therapy-resistant lung, prostate, liver, colon, pancreatic, gastric, and breast cancer cell lines, but not in non-cancerous cell lines, and decreased GRP78 in in vivo xenograft studies (76). The gene discussed is HSPA5; the disease is breast carcinoma.